HELLS and central nervous system cancer: Multiple studies have shown that HELLS knockdown in vitro results in decreased proliferation of various cancer cell types including retinoblastoma [20], gliomas [24], nasopharyngeal [27] and breast cancer [34] cells, and that engraftment of cells carrying ectopically expressed HELLS gives rise to heavier tumor burden.